Inavolisib Added to Standard Tx Shows Sustained Benefit in Advanced BCJune 19, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Doctors Endorsing Products on X May Not Disclose Company TiesJune 19, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGene Therapy
One Patient Changed This Oncologist’s View of Hope. Here’s How.June 19, 2024Patient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
ChatGPT Enhances Readability of Cancer Information for PatientsJune 18, 2024Patient & Survivor CarePractice Management
FDA Expands Durvalumab Label to Endometrial CancerJune 18, 2024Gynecologic CancerPatient & Survivor Care
Surviving to Thriving: Enhancing Quality of Life in Breast CancerJune 17, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
FDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid TumorsJune 14, 2024Patient & Survivor CareLung CancerPractice ManagementCNS/Brain CancerBreast CancerGastrointestinal CancerGenitourinary Cancer
Engineering Mind Helps Investigator Develop New Cancer TherapiesJune 13, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor Care
AI Patient Navigator Helps Re-Engage Underserved Patients After Missed ColonoscopyJune 13, 2024GastroenterologyGastrointestinal Cancer
Could British Columbia Eliminate Cervical Cancer by 2031?June 12, 2024Gynecologic CancerGenitourinary CancerPreventive CareDiversity in Medicine
